In the medical sector, even the smallest failure can have critical consequences, making acceptable DOA rates virtually zero. This article reveals why damage still occurs and how companies can move from reactive fixes to proactive, packaging-driven prevention. Discover how to reduce risks, lower hidden costs, and build a zero-defect supply chain.
Summary of this article
DOA percentages in the medical sector typically range from 0.1% to 3%, depending on the product type and transportation complexity. Medical devices and pharmaceuticals require extremely low DOA rates due to patient safety implications and operational demands. Acceptable rates vary significantly between basic supplies (2–3%), complex medical equipment (0.5–1%), and sterile instruments (0.1–0.5%). Understanding these benchmarks helps healthcare organisations maintain quality standards while optimising their supply chains.
Dead on Arrival (DOA) in the medical sector refers to products that arrive damaged, defective, or unusable at their destination. Unlike other industries where DOA might simply mean inconvenience or cost, medical DOA incidents can directly impact patient care and safety.
In healthcare, DOA encompasses several critical scenarios. Medical devices that arrive with damaged components cannot be used in procedures. Pharmaceuticals with compromised packaging may be contaminated or have reduced efficacy. Sterile instruments with breached packaging lose their sterility and become unusable in surgical environments.
The consequences extend beyond the immediate product loss. When a surgical instrument arrives damaged on the day of an operation, it can delay procedures, affect patient outcomes, and create significant operational disruption. Emergency medical supplies that arrive unusable can compromise critical care situations where time is absolutely vital.
Medical DOA rates are measured differently than in consumer goods industries. The focus is on functional integrity rather than cosmetic appearance. A medical device with a minor scratch might be acceptable, but one with compromised seals or damaged electronic components would be classified as DOA regardless of its external appearance.
Medical device DOA rates typically range from 0.5% to 1.5% for standard equipment, while complex diagnostic machines often achieve rates below 0.5%. The variation depends heavily on product sensitivity and transportation requirements.
Basic medical supplies like bandages, syringes, and disposable items generally have acceptable DOA rates of 2–3%. These products are less sensitive to minor handling issues and are often shipped in bulk quantities where small losses are economically acceptable.
Pharmaceutical products maintain stricter standards, with acceptable DOA rates between 0.2% and 1%. Temperature-sensitive medications require even lower rates, often below 0.5%, due to the critical importance of maintaining cold chain integrity throughout transport.
Sterile surgical instruments demand the lowest DOA tolerances, typically 0.1% to 0.5%. Any compromise to sterile packaging renders these products unusable, making protective packaging and careful handling absolutely necessary.
High-value diagnostic equipment and imaging devices often achieve DOA rates below 0.3%. These products receive premium packaging and handling protocols due to their cost and the operational impact of receiving damaged equipment.
DOA incidents in healthcare directly affect patient care, surgical schedules, and emergency response capabilities. Unlike other sectors where damaged goods cause primarily financial inconvenience, medical DOA incidents can impact life-saving treatments and procedures.
Surgical departments operate on tight schedules with little room for equipment failures. When a critical instrument arrives damaged, it can delay operations, extend patient waiting times, and disrupt entire surgical programmes. The ripple effects include increased anaesthesia time, extended facility usage, and potential complications from delayed treatment.
Emergency departments require immediate access to functional equipment. DOA medical supplies in emergency situations can compromise patient care when alternative products are not immediately available. The time lost sourcing replacement equipment can be critical in life-threatening situations.
Financial implications extend beyond replacement costs. Healthcare facilities often maintain expensive backup inventory to mitigate DOA risks. High DOA rates force hospitals to carry larger safety stocks, increasing storage costs and capital requirements.
Regulatory compliance adds another layer of complexity. Medical facilities must document and report equipment failures, including DOA incidents. High DOA rates can trigger regulatory scrutiny and require extensive documentation of quality control measures.
Medical companies can reduce DOA rates through improved packaging design, enhanced quality control protocols, and optimised transportation procedures. The most effective approach combines protective packaging with systematic process improvements throughout the supply chain.
Quality control measures should begin at the manufacturing stage with robust pre-shipment testing. Products need thorough inspection before packaging, with particular attention to components that are vulnerable during transport. Implementing standardised quality checkpoints helps identify potential issues before products leave the facility.
Transportation protocols require careful consideration of handling procedures and carrier selection. Training shipping personnel on medical product requirements and establishing clear handling guidelines reduces damage during transit. Using carriers experienced with medical products often results in lower DOA rates.
Environmental monitoring during transport helps identify conditions that contribute to product damage. Temperature sensors, shock indicators, and humidity monitors provide data on transport conditions, allowing companies to identify and address problematic shipping routes or handling procedures.
Packaging design plays a fundamental role in DOA prevention. Custom protective packaging that accounts for specific product vulnerabilities provides the foundation for successful medical product transport. The packaging must protect against impacts, vibration, temperature fluctuations, and contamination risks.
An acceptable DOA percentage is not only the result of careful handling or reliable transport. In many cases, it is determined much earlier: when the packaging concept is defined. For medical devices, instruments and sensitive components, protection has to be designed around the product, the route and the way it will actually be used in practice.
This is where a standard case or off-the-shelf packaging solution is often not enough. A medical product may be sensitive to shock, vibration, moisture, temperature changes or incorrect handling. It may also have specific requirements around cleaning, documentation, traceability or certification. If these factors are not considered at the start, the risk of DOA remains present throughout the supply chain.
At Faes, we approach this as an engineering challenge. We translate technical and operational requirements into packaging solutions that are specific enough to reduce risk, but practical enough to work in daily logistics. That can include custom case engineering, foam design, product fixation, assembly, system integration and testing. The goal is not to overpackage a product, but to understand where failure can occur and design those risks out of the packaging concept.
For medical companies, this means packaging becomes more than protection during transport. It becomes part of the quality process. A well-designed packaging solution helps keep products functional, consistent and ready for use when they arrive. That is ultimately what reducing DOA is about: not accepting failure as a logistics issue, but preventing it through better design, specification and validation.
Specialised medical packaging solutions focus on custom protective designs, environmental control, and sterile packaging maintenance. Effective medical packaging addresses the unique vulnerabilities of healthcare products while maintaining regulatory compliance throughout transport.
Custom protective packaging provides tailored protection for specific medical devices. Foam interiors designed around product geometry absorb impacts and prevent movement during transport. Rigid outer cases protect against crushing forces and environmental hazards that could compromise product integrity.
Temperature-controlled packaging maintains pharmaceutical efficacy during transport. Insulated containers with phase change materials or active cooling systems preserve required temperature ranges. These solutions are particularly important for biologics and vaccines that lose potency when exposed to temperature excursions.
Shock absorption systems protect sensitive electronic medical equipment from vibration and impact damage. Multi-layer cushioning systems and suspension mounting reduce transmitted forces during handling and transport. These approaches are vital for diagnostic equipment and monitoring devices with delicate internal components.
Sterile packaging maintenance requires specialised barrier materials and sealing techniques. Medical-grade packaging materials resist punctures and maintain sterile barriers throughout the supply chain. Proper sealing methods ensure package integrity while allowing for easy opening in clinical environments.
Professional packaging management services help medical companies optimise their entire packaging process. These services analyse current DOA rates, identify improvement opportunities, and implement systematic solutions that reduce product damage while maintaining cost-effectiveness.
Measure DOA rates monthly to gain a reliable picture of trends and seasonal variations. For critical equipment, weekly monitoring is recommended. Report quarterly figures to suppliers and use this data for contract negotiations and supplier evaluations.
Always document the damage with photographs, the original packaging, transport labels and a detailed description of the fault. For medical devices, an impact assessment is also required, in which you describe how the fault affects patient care. Keep all documents for at least 5 years to ensure traceability.
Yes, DOA data is a powerful negotiating tool. Set specific requirements in contracts, such as a maximum of 1% DOA for standard equipment or financial compensation if this limit is exceeded. Also request transparent reporting from suppliers regarding their own quality controls and packaging processes.
DOA is identified within 24–48 hours of receipt, before the device is put into use. Damage discovered later falls under warranty or maintenance. For medical devices, this timeframe is crucial because devices often need to be installed and calibrated immediately after delivery.
Organise practical training sessions using examples of typical transport damage to medical equipment. Teach staff to carry out systematic inspections: first a visual check, then functional testing in accordance with protocol. Ensure there are clear reporting procedures and a central database where all DOA incidents are recorded.
Temperature fluctuations can damage electronic components and calibrations without causing visible damage. Use data loggers during transport and set temperature limits for each type of device. For sensitive devices such as laboratory analysers, climate-controlled transport is often essential to prevent DOA.
Carlo Leijten is an account manager at Faes specializing in medical applications and audiovisual equipment. He helps customers in these plastics industries develop customized packaging solutions that meet stringent requirements for protection, cleanability and mobility.
More articles by Carlo LeijtenGood packaging doesn’t just happen by chance. Using a tried-and-tested approach, our specialists guide you step by step from the initial idea to the finished product.
